Needle vs. scope: which ablation method wins for lung cancer?
NCT ID NCT06503744
First seen May 01, 2026 · Last updated May 15, 2026 · Updated 3 times
Summary
This study compares two minimally invasive procedures—transthoracic (through the chest wall) and transbronchial (through the airways)—to destroy early-stage lung cancer tumors using heat. About 110 adults with stage IA peripheral lung cancer who cannot or choose not to have surgery will be randomly assigned to one method. The main goal is to see which approach completely ablates more tumors at 6 months, with fewer side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER STAGE IA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Chest Hospital
RECRUITINGShanghai, Shanghai Municipality, 200030, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.